Thus, a decrease of tumor-suppressors, such as p53 and RB proteins, or an increase of proto-oncogene levels, for example MYC and epidermal growth factor receptor (EGFR), are frequent events in primary tumors [10,11]. This evidence concerns the gene TP53 and neoplasm.